Introduction
Table of Contents
Candidemia and invasive Candida infections are among the most common fungal diseases in hospitalized and immunocompromised patients. Traditional diagnosis by blood culture is often slow and has limited sensitivity. Candida antigen testing provides a rapid, non-culture-based method for detecting circulating fungal components in blood or serum, supporting early diagnosis and management of invasive candidiasis.
Principle
- Target Antigens: Candida antigen tests detect circulating mannan antigen (a major polysaccharide cell wall component of Candida).
- Assay Methods:
- Latex agglutination tests: Detect mannan or Candida cell wall antigens through visible agglutination.
- Enzyme immunoassays (EIA/ELISA): Capture and detect antigens with enzyme-labeled antibodies, providing higher sensitivity.
- Combined antigen-antibody assays (Mannan/anti-Mannan): Increase sensitivity by detecting both antigen and host antibody responses.
- Interpretation: A positive test suggests the presence of circulating Candida antigens, indicating an invasive infection rather than colonization.
Clinical Significance
- Early Diagnosis: Detects Candida antigens before cultures become positive, enabling timely antifungal therapy.
- Broad Use: Helpful in high-risk groups such as oncology, transplant, ICU, and neutropenic patients.
- Adjunct to Culture: Supports culture-based diagnosis; useful when blood culture is negative but clinical suspicion is high.
- Species Insight: While not species-specific, combined testing with antibody assays and molecular methods improves diagnostic yield.
- Monitoring: Can be used for disease progression and treatment response, as antigen levels decline with effective therapy.
- Limitations:
- Cross-reactivity with other fungi may occur.
- Lower sensitivity in localized candidiasis or low fungal burden.
- Cannot provide antifungal susceptibility data.
Keynotes
- Candida antigen testing detects mannan antigen, a reliable biomarker for invasive candidiasis.
- Techniques: Latex agglutination, ELISA, and combined antigen-antibody detection.
- Offers rapid, non-culture-based diagnosis and can guide early therapy.
- Sensitivity is increased when antigen + antibody detection is combined.
- Best used as an adjunct to culture, molecular assays, or β-D-glucan testing.
- Plays a key role in oncology, transplant, and ICU patients at high risk of invasive Candida infections.
Further Readings
- https://www.sciencedirect.com/topics/immunology-and-microbiology/candida-antigen
- https://academic.oup.com/mmy/article/52/5/462/2802510
- https://pmc.ncbi.nlm.nih.gov/articles/PMC9219674/
- https://commerce.bio-rad.com/webroot/web/pdf/inserts/CDG/en/52952_880072_EN.pdf
- https://nutripath.com.au/product/candida-antibodies-antigen-test-code-3001-or-3002/
- https://www.sciencedirect.com/topics/medicine-and-dentistry/fungus-antigen
- https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9989527/
- https://www.sciencedirect.com/science/article/abs/pii/S1386653203000027
- https://link.springer.com/chapter/10.1007/978-981-97-4909-6_1
- https://mid.journals.ekb.eg/article_320661.html